Given that vasculopathy is an early event in SSc pathogenesis, endothelial damage occurring during the initial stages of the disease may activate platelets, leading to subsequent release of mediators such as CXCL4 (50), linking autoimmunity and fibrosis by its effects on monocytes (51, 52). Here, PF4 is linked to vascular disorder.